CONTINUUS Team meets FDA
- CONTINUUS Pharma
- Jul 13, 2017
- 1 min read
Updated: Aug 7, 2024
Thursday, July 13th, 2017 - General News
The CONTINUUS Team has met with key FDA representatives for a progress update on the implementation of our end-to-end Integrated Continuous Manufacturing (ICM) process. The picture below includes (from the left) Sap Chattopadhyay, Stephen Born, Salvatore Mascia, Bayan Takizawa, Vida Arya, Christopher Testa and Chuntian Hu.
Comments